Literature DB >> 21189492

The genetics and clinical manifestations of telomere biology disorders.

Sharon A Savage1, Alison A Bertuch.   

Abstract

Telomere biology disorders are a complex set of illnesses defined by the presence of very short telomeres. Individuals with classic dyskeratosis congenita have the most severe phenotype, characterized by the triad of nail dystrophy, abnormal skin pigmentation, and oral leukoplakia. More significantly, these individuals are at very high risk of bone marrow failure, cancer, and pulmonary fibrosis. A mutation in one of six different telomere biology genes can be identified in 50–60% of these individuals. DKC1, TERC, TERT, NOP10, and NHP2 encode components of telomerase or a telomerase-associated factor and TINF2, a telomeric protein. Progressively shorter telomeres are inherited from generation to generation in autosomal dominant dyskeratosis congenita, resulting in disease anticipation. Up to 10% of individuals with apparently acquired aplastic anemia or idiopathic pulmonary fibrosis also have short telomeres and mutations in TERC or TERT. Similar findings have been seen in individuals with liver fibrosis or acute myelogenous leukemia. This report reviews basic aspects of telomere biology and telomere length measurement, and the clinical and genetic features of those disorders that constitute our current understanding of the spectrum of illness caused by defects in telomere biology. We also suggest a grouping schema for the telomere disorders.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21189492      PMCID: PMC3825100          DOI: 10.1097/GIM.0b013e3181f415b5

Source DB:  PubMed          Journal:  Genet Med        ISSN: 1098-3600            Impact factor:   8.822


  130 in total

1.  Mutations in dyskeratosis congenita: their impact on telomere length and the diversity of clinical presentation.

Authors:  Tom J Vulliamy; Anna Marrone; Stuart W Knight; Amanda Walne; Philip J Mason; Inderjeet Dokal
Journal:  Blood       Date:  2005-12-06       Impact factor: 22.113

2.  Intensive immunosuppression therapy for aplastic anemia associated with dyskeratosis congenita.

Authors:  Mohamad M Al-Rahawan; Neelam Giri; Blanche P Alter
Journal:  Int J Hematol       Date:  2006-04       Impact factor: 2.490

3.  TERC and TERT gene mutations in patients with bone marrow failure and the significance of telomere length measurements.

Authors:  Hong-Yan Du; Elena Pumbo; Jennifer Ivanovich; Ping An; Richard T Maziarz; Ulrike M Reiss; Deborah Chirnomas; Akiko Shimamura; Adrianna Vlachos; Jeffrey M Lipton; Rakesh K Goyal; Frederick Goldman; David B Wilson; Philip J Mason; Monica Bessler
Journal:  Blood       Date:  2008-10-17       Impact factor: 22.113

Review 4.  The box H/ACA ribonucleoprotein complex: interplay of RNA and protein structures in post-transcriptional RNA modification.

Authors:  Tomoko Hamma; Adrian R Ferré-D'Amaré
Journal:  J Biol Chem       Date:  2009-11-16       Impact factor: 5.157

5.  The DNMT3B DNA methyltransferase gene is mutated in the ICF immunodeficiency syndrome.

Authors:  R S Hansen; C Wijmenga; P Luo; A M Stanek; T K Canfield; C M Weemaes; S M Gartler
Journal:  Proc Natl Acad Sci U S A       Date:  1999-12-07       Impact factor: 11.205

Review 6.  New developments in telomere length analysis.

Authors:  Duncan M Baird
Journal:  Exp Gerontol       Date:  2005-03-29       Impact factor: 4.032

7.  A prospective study of telomere length and the risk of skin cancer.

Authors:  Jiali Han; Abrar A Qureshi; Jennifer Prescott; Qun Guo; Li Ye; David J Hunter; Immaculata De Vivo
Journal:  J Invest Dermatol       Date:  2008-07-31       Impact factor: 8.551

8.  Unusual complications after bone marrow transplantation for dyskeratosis congenita.

Authors:  V Rocha; A Devergie; G Socié; P Ribaud; H Espérou; N Parquet; E Gluckman
Journal:  Br J Haematol       Date:  1998-10       Impact factor: 6.998

9.  The TNF2 allele is a risk factor to severe aplastic anemia independent of HLA-DR.

Authors:  Jun Peng; Chuanfang Liu; Kunli Zhu; Yuanyuan Zhu; Yuan Yu; Jie Li; Ming Hou; Xueliang Chen; Conggao Xu; Maohong Zhang
Journal:  Hum Immunol       Date:  2003-09       Impact factor: 2.850

Review 10.  Aplastic anemia.

Authors:  Neal S Young; Phillip Scheinberg; Rodrigo T Calado
Journal:  Curr Opin Hematol       Date:  2008-05       Impact factor: 3.284

View more
  106 in total

1.  Mutations in CTC1, encoding conserved telomere maintenance component 1, cause Coats plus.

Authors:  Beverley H Anderson; Paul R Kasher; Josephine Mayer; Marcin Szynkiewicz; Emma M Jenkinson; Sanjeev S Bhaskar; Jill E Urquhart; Sarah B Daly; Jonathan E Dickerson; James O'Sullivan; Elisabeth Oppliger Leibundgut; Joanne Muter; Ghada M H Abdel-Salem; Riyana Babul-Hirji; Peter Baxter; Andrea Berger; Luisa Bonafé; Janice E Brunstom-Hernandez; Johannes A Buckard; David Chitayat; Wui K Chong; Duccio M Cordelli; Patrick Ferreira; Joel Fluss; Ewan H Forrest; Emilio Franzoni; Caterina Garone; Simon R Hammans; Gunnar Houge; Imelda Hughes; Sebastien Jacquemont; Pierre-Yves Jeannet; Rosalind J Jefferson; Ram Kumar; Georg Kutschke; Staffan Lundberg; Charles M Lourenço; Ramesh Mehta; Sakkubai Naidu; Ken K Nischal; Luís Nunes; Katrin Ounap; Michel Philippart; Prab Prabhakar; Sarah R Risen; Raphael Schiffmann; Calvin Soh; John B P Stephenson; Helen Stewart; Jon Stone; John L Tolmie; Marjo S van der Knaap; Jose P Vieira; Catheline N Vilain; Emma L Wakeling; Vanessa Wermenbol; Andrea Whitney; Simon C Lovell; Stefan Meyer; John H Livingston; Gabriela M Baerlocher; Graeme C M Black; Gillian I Rice; Yanick J Crow
Journal:  Nat Genet       Date:  2012-01-22       Impact factor: 38.330

2.  Connecting complex disorders through biology.

Authors:  Sharon A Savage
Journal:  Nat Genet       Date:  2012-02-27       Impact factor: 38.330

Review 3.  Telomeres and immune competency.

Authors:  Nan-ping Weng
Journal:  Curr Opin Immunol       Date:  2012-05-22       Impact factor: 7.486

Review 4.  Understanding telomere diseases through analysis of patient-derived iPS cells.

Authors:  Luis F Z Batista; Steven E Artandi
Journal:  Curr Opin Genet Dev       Date:  2013-08-28       Impact factor: 5.578

5.  Cytokine production by bone marrow mononuclear cells in inherited bone marrow failure syndromes.

Authors:  Ken Matsui; Neelam Giri; Blanche P Alter; Ligia A Pinto
Journal:  Br J Haematol       Date:  2013-07-25       Impact factor: 6.998

Review 6.  Telomere dynamics in mice and humans.

Authors:  Rodrigo T Calado; Bogdan Dumitriu
Journal:  Semin Hematol       Date:  2013-04       Impact factor: 3.851

7.  Similar telomere attrition rates in androgen-treated and untreated patients with dyskeratosis congenita.

Authors:  Payal P Khincha; Alison A Bertuch; Shahinaz M Gadalla; Neelam Giri; Blanche P Alter; Sharon A Savage
Journal:  Blood Adv       Date:  2018-06-12

Review 8.  Periodontal and other oral manifestations of immunodeficiency diseases.

Authors:  M E Peacock; R M Arce; C W Cutler
Journal:  Oral Dis       Date:  2016-10-10       Impact factor: 3.511

9.  Super-resolution fluorescence imaging of telomeres reveals TRF2-dependent T-loop formation.

Authors:  Ylli Doksani; John Y Wu; Titia de Lange; Xiaowei Zhuang
Journal:  Cell       Date:  2013-10-10       Impact factor: 41.582

10.  Germline mutations of regulator of telomere elongation helicase 1, RTEL1, in Dyskeratosis congenita.

Authors:  Bari J Ballew; Meredith Yeager; Kevin Jacobs; Neelam Giri; Joseph Boland; Laurie Burdett; Blanche P Alter; Sharon A Savage
Journal:  Hum Genet       Date:  2013-01-18       Impact factor: 4.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.